Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Palivizumab-like neutralization antibody"'
Autor:
Nao Jounai, Megumi Yoshioka, Miyuki Tozuka, Kazue Inoue, Tatsuya Oka, Kazuki Miyaji, Katsuyasu Ishida, Naoki Kawai, Hideyuki Ikematsu, Chiaki Kawakami, Hiroyuki Shimizu, Masaaki Mori, Ken J. Ishii, Fumihiko Takeshita
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 124-135 (2017)
Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory tract infections worldwide, especially in infants around 3 to 4 months old. Infants at such a young age have maternally-transferred passive antibodie
Externí odkaz:
https://doaj.org/article/b40c38bc15cb4dbab430c322580a0d67
Autor:
Bert Schepens, Xavier Saelens
Publikováno v:
EBioMedicine
EBioMedicine, Vol 16, Iss C, Pp 10-11 (2017)
EBioMedicine, Vol 16, Iss C, Pp 10-11 (2017)
Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory tract infections worldwide, especially in infants around 3 to 4 months old. Infants at such a young age have maternally-transferred passive antibodie
Autor:
Kazuki Miyaji, Fumihiko Takeshita, Hideyuki Ikematsu, Megumi Yoshioka, Masaaki Mori, Naoki Kawai, Nao Jounai, Kazue Inoue, Hiroyuki Shimizu, Katsuyasu Ishida, Chiaki Kawakami, Miyuki Tozuka, Tatsuya Oka, Ken Ishii
Publikováno v:
EBioMedicine, Vol 16, Iss C, Pp 124-135 (2017)
Respiratory syncytial virus (RSV) is one of the most prevalent causative agents of lower respiratory tract infections worldwide, especially in infants around 3 to 4months old. Infants at such a young age have maternally-transferred passive antibodies
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.